Trial Outcomes & Findings for Impact of Exclusive Use of Low Nicotine Cigarettes on Compensatory Smoking (NCT NCT03311646)

NCT ID: NCT03311646

Last Updated: 2020-01-28

Results Overview

Measure of short term smoke exposure, higher scores indicate more smoke exposure. While in the hotel, participants provided breath samples at 8am, 12pm, 4pm, 8pm beginning with 4pm on Day 1 and ending with 12pm on Day 5. Outcome here are from the VLNC condition. Baseline (NNC) data are reported in the baseline characteristics section.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

31 participants

Primary outcome timeframe

8am, 12pm, 4pm, 8pm beginning with 4pm on Day 1 and ending with 12pm on Day 5

Results posted on

2020-01-28

Participant Flow

Participants were screened for eligibility prior to the baseline condition. Participants were then required to return to the lab on a designated date to complete an additional drug screen and begin the hotel phase. Participants could withdraw or be lost to follow up between screening and baseline.

Participant milestones

Participant milestones
Measure
Very Low Nicotine Content
All participants receive normal nicotine content (NNC) cigarettes during baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition.
Overall Study
STARTED
31
Overall Study
COMPLETED
16
Overall Study
NOT COMPLETED
15

Reasons for withdrawal

Reasons for withdrawal
Measure
Very Low Nicotine Content
All participants receive normal nicotine content (NNC) cigarettes during baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition.
Overall Study
Physician Decision
1
Overall Study
Withdrawal by Subject
5
Overall Study
Lost to Follow-up
5
Overall Study
PI Withdrawal for Positive Drug Screen
4

Baseline Characteristics

Impact of Exclusive Use of Low Nicotine Cigarettes on Compensatory Smoking

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Nicotine Content Manipulation
n=16 Participants
All participants receive normal nicotine content (NNC) cigarettes during Baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition. During both the NNC and VLNC conditions, participants stay in a hotel and exclusively use the cigarettes provided to them. Each condition lasts four nights / five days. Baseline outcomes for the NNC condition are reported below, and VLNC condition outcomes are reported in the results section.
Age, Continuous
38.87 years
n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
14 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
Region of Enrollment
United States
16 participants
n=5 Participants
Education: Some College or More
8 Participants
n=5 Participants
Usual cigarette brand is menthol
7 Participants
n=5 Participants
Self-reported cigarettes per day at screening
14.75 cigarettes per day
n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 1 (4pm)
17.16 parts per million
STANDARD_DEVIATION 6.95 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 1 (8pm)
31.26 parts per million
STANDARD_DEVIATION 15.26 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 2 (8am)
23.97 parts per million
STANDARD_DEVIATION 12.15 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 2 (12pm)
32.16 parts per million
STANDARD_DEVIATION 16.32 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 2 (4pm)
32.78 parts per million
STANDARD_DEVIATION 16.87 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 2 (8pm)
32.74 parts per million
STANDARD_DEVIATION 16.87 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 3 (8am)
24.60 parts per million
STANDARD_DEVIATION 10.16 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 3 (12pm)
30.30 parts per million
STANDARD_DEVIATION 16.31 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 3 (4pm)
29.06 parts per million
STANDARD_DEVIATION 16.83 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 3 (8pm)
30.72 parts per million
STANDARD_DEVIATION 15.61 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 4 (8am)
21.94 parts per million
STANDARD_DEVIATION 11.74 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 4 (12pm)
30.38 parts per million
STANDARD_DEVIATION 16.74 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 4 (4pm)
31.61 parts per million
STANDARD_DEVIATION 18.16 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 4 (8pm)
32.09 parts per million
STANDARD_DEVIATION 17.65 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 5 (8am)
26.39 parts per million
STANDARD_DEVIATION 14.19 • n=5 Participants
Breath Sample (Expired Carbon Monoxide)
Day 5 (12pm)
33.95 parts per million
STANDARD_DEVIATION 17.11 • n=5 Participants
Average cigarettes smoked per day
1st 24-hr sample
17.69 cigarettes per day
STANDARD_DEVIATION 8.26 • n=5 Participants
Average cigarettes smoked per day
2nd 24-hr sample
19.13 cigarettes per day
STANDARD_DEVIATION 7.87 • n=5 Participants
Average cigarettes smoked per day
3rd 24-hr sample
19.13 cigarettes per day
STANDARD_DEVIATION 9.01 • n=5 Participants
Average cigarettes smoked per day
4th 24-hr sample
21.88 cigarettes per day
STANDARD_DEVIATION 9.13 • n=5 Participants
Minnesota Nicotine Withdrawal Scale
Day 2
20.44 units on a scale
STANDARD_DEVIATION 4.46 • n=5 Participants
Minnesota Nicotine Withdrawal Scale
Day 3
21.13 units on a scale
STANDARD_DEVIATION 5.02 • n=5 Participants
Minnesota Nicotine Withdrawal Scale
Day 4
21.13 units on a scale
STANDARD_DEVIATION 4.47 • n=5 Participants
Minnesota Nicotine Withdrawal Scale
Day 5
21.38 units on a scale
STANDARD_DEVIATION 4.56 • n=5 Participants
Questionnaire of Smoking Urges
Day 2
19.25 units on a scale
STANDARD_DEVIATION 10.50 • n=5 Participants
Questionnaire of Smoking Urges
Day 3
22.06 units on a scale
STANDARD_DEVIATION 12.13 • n=5 Participants
Questionnaire of Smoking Urges
Day 4
18.94 units on a scale
STANDARD_DEVIATION 12.91 • n=5 Participants
Questionnaire of Smoking Urges
Day 5
19.00 units on a scale
STANDARD_DEVIATION 10.58 • n=5 Participants

PRIMARY outcome

Timeframe: 8am, 12pm, 4pm, 8pm beginning with 4pm on Day 1 and ending with 12pm on Day 5

Population: Results are presented for the 16 participants who completed both the NNC (baseline) and the VLNC conditions. Not an intent to treat trial.

Measure of short term smoke exposure, higher scores indicate more smoke exposure. While in the hotel, participants provided breath samples at 8am, 12pm, 4pm, 8pm beginning with 4pm on Day 1 and ending with 12pm on Day 5. Outcome here are from the VLNC condition. Baseline (NNC) data are reported in the baseline characteristics section.

Outcome measures

Outcome measures
Measure
Very Low Nicotine Content
n=16 Participants
All participants receive normal nicotine content (NNC) cigarettes during baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition.
Breath Sample (Expired Carbon Monoxide)
Day 1 (4pm)
18.77 parts per million
Standard Deviation 8.12
Breath Sample (Expired Carbon Monoxide)
Day 1 (8pm)
31.07 parts per million
Standard Deviation 18.74
Breath Sample (Expired Carbon Monoxide)
Day 2 (8am)
25.38 parts per million
Standard Deviation 14.51
Breath Sample (Expired Carbon Monoxide)
Day 2 (12pm)
30.49 parts per million
Standard Deviation 16.04
Breath Sample (Expired Carbon Monoxide)
Day 2 (4pm)
36.72 parts per million
Standard Deviation 24.68
Breath Sample (Expired Carbon Monoxide)
Day 2 (8pm)
35.66 parts per million
Standard Deviation 18.79
Breath Sample (Expired Carbon Monoxide)
Day 3 (8am)
26.06 parts per million
Standard Deviation 13.62
Breath Sample (Expired Carbon Monoxide)
Day 3 (12pm)
31.65 parts per million
Standard Deviation 18.59
Breath Sample (Expired Carbon Monoxide)
Day 3 (4pm)
31.90 parts per million
Standard Deviation 17.47
Breath Sample (Expired Carbon Monoxide)
Day 3 (8pm)
34.14 parts per million
Standard Deviation 17.81
Breath Sample (Expired Carbon Monoxide)
Day 4 (8am)
23.27 parts per million
Standard Deviation 14.28
Breath Sample (Expired Carbon Monoxide)
Day 4 (12pm)
24.82 parts per million
Standard Deviation 14.09
Breath Sample (Expired Carbon Monoxide)
Day 4 (4pm)
28.99 parts per million
Standard Deviation 16.03
Breath Sample (Expired Carbon Monoxide)
Day 4 (8pm)
30.03 parts per million
Standard Deviation 17.25
Breath Sample (Expired Carbon Monoxide)
Day 5 (8am)
22.22 parts per million
Standard Deviation 13.18
Breath Sample (Expired Carbon Monoxide)
Day 5 (12pm)
30.99 parts per million
Standard Deviation 17.07

PRIMARY outcome

Timeframe: Participants returned smoked cigarette butts each day at 12pm, creating four 24-hr samples for each hotel phase. Data reported here are for the four 24-hr samples of the VLNC condition.

Population: Results are presented for the 16 participants who completed both the NNC (baseline) and the VLNC conditions. Not an intent to treat trial.

Measure of smoking behavior. Participants returned smoked cigarette butts each day at 12pm, creating four 24-hr samples for each hotel phase (NNC and VLNC). Outcomes reported here are from the VLNC condition. Baseline (NNC) data are reported in the baseline characteristics section.

Outcome measures

Outcome measures
Measure
Very Low Nicotine Content
n=16 Participants
All participants receive normal nicotine content (NNC) cigarettes during baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition.
Average Cigarettes Smoked Per Day
1st 24-hr sample
19.13 Cigarettes per day
Standard Deviation 11.99
Average Cigarettes Smoked Per Day
2nd 24-hr sample
22.38 Cigarettes per day
Standard Deviation 14.69
Average Cigarettes Smoked Per Day
3rd 24-hr sample
20.13 Cigarettes per day
Standard Deviation 13.11
Average Cigarettes Smoked Per Day
4th 24-hr sample
20.69 Cigarettes per day
Standard Deviation 13.31

SECONDARY outcome

Timeframe: Participants complete this self-report questionnaire on Days 2-5 during the NNC (Baseline) and VLNC conditions. Presented here are the scores from the VLNC condition.

Population: Results are presented for the 16 participants who completed both the NNC (baseline) and the VLNC conditions. Not an intent to treat trial.

Measure of withdrawal, Total Score is presented here, Range from 0-60 with higher scores indicating greater withdrawal. Participants complete this self-report questionnaire on Days 2-5 during the NNC (Baseline) and VLNC conditions. Presented here are the scores from the VLNC condition. Data from the NNC (Baseline) conditions are reported in the baseline section.

Outcome measures

Outcome measures
Measure
Very Low Nicotine Content
n=16 Participants
All participants receive normal nicotine content (NNC) cigarettes during baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition.
Minnesota Nicotine Withdrawal Scale
Day 4
23.69 units on a scale
Standard Deviation 7.51
Minnesota Nicotine Withdrawal Scale
Day 5
25.00 units on a scale
Standard Deviation 9.36
Minnesota Nicotine Withdrawal Scale
Day 2
23.94 units on a scale
Standard Deviation 8.39
Minnesota Nicotine Withdrawal Scale
Day 3
24.19 units on a scale
Standard Deviation 7.02

SECONDARY outcome

Timeframe: Participants complete the Questionnaire of Smoking Urges on Days 2-5 of both the NNC (baseline) and VLNC Condition. Data here are from the VLNC Condition.

Population: Results are presented for the 16 participants who completed both the NNC (baseline) and the VLNC conditions. Not an intent to treat trial.

Measure of craving, Range from 10-70, Higher scores indicate greater craving. Participants complete the Questionnaire of Smoking Urges on Days 2-5 of both the NNC (baseline) and VLNC Condition. Data here are from the VLNC Condition.

Outcome measures

Outcome measures
Measure
Very Low Nicotine Content
n=16 Participants
All participants receive normal nicotine content (NNC) cigarettes during baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition.
Questionnaire of Smoking Urges
Day 2
19.94 units on a scale
Standard Deviation 10.95
Questionnaire of Smoking Urges
Day 3
21.31 units on a scale
Standard Deviation 14.47
Questionnaire of Smoking Urges
Day 4
20.00 units on a scale
Standard Deviation 14.32
Questionnaire of Smoking Urges
Day 5
18.94 units on a scale
Standard Deviation 11.86

Adverse Events

Nicotine Content Manipulation

Serious events: 0 serious events
Other events: 13 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Nicotine Content Manipulation
n=16 participants at risk
All participants receive normal nicotine content (NNC) cigarettes during Baseline and all participants receive very low nicotine content (VLNC) cigarettes during the very low nicotine content condition. During both the NNC and VLNC conditions, participants stay in a hotel and exclusively use the cigarettes provided to them. Each condition lasts four nights / five days. Adverse events reported below may have been reported during either the NNC or VLNC condition.
Respiratory, thoracic and mediastinal disorders
Cough
18.8%
3/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
Respiratory, thoracic and mediastinal disorders
Sore Throat
18.8%
3/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Angry/Irritable/Frustrated Mood
12.5%
2/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
Gastrointestinal disorders
Heartburn
12.5%
2/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
Respiratory, thoracic and mediastinal disorders
Shortness of Breath
12.5%
2/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Headache
12.5%
2/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Body Pain and Achiness
12.5%
2/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
Metabolism and nutrition disorders
Change in Appetite
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Sleep Disturbances
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Craving to Smoke
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
Gastrointestinal disorders
Bowel Movement Irregularity
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Depressed Mood/ Sad
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
Gastrointestinal disorders
Nausea
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Allergic Reaction
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Body Numbness
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.
General disorders
Bug Bites
6.2%
1/16 • one month
Adverse Events were recorded either when spontaneously reported at any time during the hotel phase or when participants answered yes to the following question "Have you had any negative changes in your physical or mental health since you've been in the hotel that you think might be related to study participation?" This question was asked on Day 5 of both the NNC (baseline) and VLNC conditions. Events reported below may have been reported during either condition.

Additional Information

Dr. Tracy Smith

Medical University of South Carolina

Phone: 843-792-5164

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place